165 related articles for article (PubMed ID: 10516657)
21. Inhibition of the action of nitric oxide prodrugs by pyocyanin: mechanistic studies.
Hussain AS; Bozinovski J; Maurice DH; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1997 May; 75(5):398-406. PubMed ID: 9250373
[TBL] [Abstract][Full Text] [Related]
22. Nitrovasodilator-induced inhibition of LTB4 release from human PMN may be mediated by cyclic GMP.
Ney P; Schröder H; Schrör K
Eicosanoids; 1990; 3(4):243-5. PubMed ID: 1963541
[TBL] [Abstract][Full Text] [Related]
23. Effect of the molsidomine metabolite SIN-1 on coronary arteries and peripheral vessels of sheep with special reference to tolerance and endothelium.
Yousif MH; Yousif F; Thulesius O
Cardiovasc Drugs Ther; 1991 Aug; 5(4):769-73. PubMed ID: 1909561
[TBL] [Abstract][Full Text] [Related]
24. S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators.
Henry PJ; Drummer OH; Horowitz JD
Br J Pharmacol; 1989 Nov; 98(3):757-66. PubMed ID: 2511992
[TBL] [Abstract][Full Text] [Related]
25. Generation of NO from molsidomine (SIN-1) in vitro and its relationship to changes in coronary vessel tone.
Schrör K; Förster S; Woditsch I; Schröder H
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S29-34. PubMed ID: 2484696
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators in vivo.
Agvald P; Adding LC; Gustafsson LE; Persson MG
Eur J Pharmacol; 1999 Dec; 385(2-3):137-45. PubMed ID: 10607869
[TBL] [Abstract][Full Text] [Related]
27. Effects of estrous synchronization on response to nitric oxide donors, nitric oxide synthase inhibitors, and endothelin-1 in vitro.
Weems YS; Randel RD; Tatman S; Lewis AW; Neuendorff DA; Weems CW
Prostaglandins Other Lipid Mediat; 2004 Oct; 74(1-4):45-59. PubMed ID: 15560115
[TBL] [Abstract][Full Text] [Related]
28. NO-induced modulation of calcium-oscillations in pulmonary vascular smooth muscle.
Pauvert O; Marthan R; Savineau J
Cell Calcium; 2000 Jun; 27(6):329-38. PubMed ID: 11013463
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
30. Novel nitric oxide donors reverse endothelin-1-mediated constriction in human blood vessels.
Wiley KE; Davenport AP
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S151-2. PubMed ID: 11078363
[TBL] [Abstract][Full Text] [Related]
31. Divergent effects of vitamin C on relaxations of rabbit aortic rings to acetylcholine and NO-donors.
de Saram K; McNeill KL; Khokher S; Ritter JM; Chowienczyk PJ
Br J Pharmacol; 2002 Feb; 135(4):1044-50. PubMed ID: 11861333
[TBL] [Abstract][Full Text] [Related]
32. Cocaine induces a reversible stomatocytosis of red blood cells and increases blood viscosity.
Cagienard F; Schulzki T; Furlong P; Reinhart WH
Clin Hemorheol Microcirc; 2013; 55(3):321-9. PubMed ID: 23076010
[TBL] [Abstract][Full Text] [Related]
33. Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery.
Govantes C; Rodríguez-Martínez MA; Marín J
Methods Find Exp Clin Pharmacol; 1996; 18(6):387-95. PubMed ID: 8892268
[TBL] [Abstract][Full Text] [Related]
34. Various nitric oxide donors protect chick embryonic neurons from cyanide-induced apoptosis.
Jensen MS; Nyborg NC; Thomsen ES
Toxicol Sci; 2000 Nov; 58(1):127-34. PubMed ID: 11053549
[TBL] [Abstract][Full Text] [Related]
35. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
Van de Casteele M; Hösli M; Sägesser H; Reichen J
J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
[TBL] [Abstract][Full Text] [Related]
36. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators.
Zhou HL; Torphy TJ
J Pharmacol Exp Ther; 1991 Sep; 258(3):972-8. PubMed ID: 1679854
[TBL] [Abstract][Full Text] [Related]
37. Inotropic effects of glyceryl trinitrate and spontaneous NO donors in the dog heart.
Preckel B; Kojda G; Schlack W; Ebel D; Kottenberg K; Noack E; Thämer V
Circulation; 1997 Oct; 96(8):2675-82. PubMed ID: 9355909
[TBL] [Abstract][Full Text] [Related]
38. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
Tseng CM; Tabrizi-Fard MA; Fung HL
J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
[TBL] [Abstract][Full Text] [Related]
39. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance.
Haj-Yehia AI; Benet LZ
J Pharmacol Exp Ther; 1996 Sep; 278(3):1296-305. PubMed ID: 8819515
[TBL] [Abstract][Full Text] [Related]
40. Dissimilarity between prostaglandin E1 and nitric oxide donors as potentiators of plasma exudation in the rabbit skin in vivo.
Mariani-Pedroso SR; Bizeto L; Antunes E; Zatz R; de Nucci G
Prostaglandins Leukot Essent Fatty Acids; 1995 Jun; 52(6):399-402. PubMed ID: 7644562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
